INTRODUCTION
classes, the penicillins and cephalosporins (see Fig. 1 ). The central feature of the antibiotic General nucleus is the highly strained beta-lactam ring.
The beta-lactam antibiotics stand out among As discussed below, this ring may be that part antimicrobial agents for-their wide spectrum of of the molecule which reacts with the penicillin activity and for their remarkably low toxicity to target. The side chains attached to the nucleus animals. These substances are composed of two ple, render the penicillin resistant to degradation by penicillinase, tolerant of gastric acidity, or able to penetrate the outer envelope of gram-negative organisms.
Since the introduction of penicillin into general medical practice, a continual problem has been the emergence of drug-resistant strains of bacteria (201) . In many cases this resistance has been shown to arise from production of beta-lactamase (penicillinase), an enzyme which degrades the antibiotic. In other cases, the intrinsic sensitivity of the organism is what appears to have been altered. Synthesis of novel penicillin derivatives has fortunately kept pace so far with the appearance of penicillin-resistant bacterial strains. In order to maintain such progress, a detailed understanding of the mode of action of penicillin in killing bacteria, and the nature of the interaction between penicillin and its receptor should be valuable.
The remarkably low toxicity of penicillin for animals suggests that the drug inhibits some bacterial structure or function without analogue in higher organisms. In fact, the target of penicillin has been demonstrated to be the bacterial cell wall, a unique microbial structure. (A trivial exception to this generalization exists [204] . The cephalosporin 7-(5-benzyl-thioacetamido)-cephem-3-ylmethyl-N-dimethyldithiocarbamate-4-carboxylic acid also inhibits protein synthesis and thus is active against both fungi and bacterial spheroplasts. Apparently, the cephalosporin decomposes to liberate the dimethyldithiocarbamate in the 3-position on the molecule. This hydrolysis product is responsible for the unusual antibiotic behavior.) The cell wall is a giant macromolecule which envelopes the organism, supporting the bacterial cell membrane against lysis caused by the difference in osmolarity between the cell cytoplasm and the culture medium, which is relatively hypotonic. Because cell wall synthesized in the presence of penicillin is weak and unable to provide the cell with this needed osmotic support, penicillin lyses growing bacteria. Consistent with this explanation, penicillin does not kill cells growing in sufficiently hypertonic medium. Likewise, bacteria are protected from the action of penicillin in the absence of cell growth, in which case new cell wall synthesis is not required.
The action of penicillin as an inhibitor of cell wall biosynthesis offers a second important reason for studying the interaction of this drug with the bacterial cell. Many fundamental, but poorly understood, phenomena are related to cell wall synthesis: morphogenesis-the cell wall is responsible for maintaining the shape of the bacterium. What regulates the shape assumed by the cell wall? Cell division-division is by definition the formation of a septum containing cell wall and cell membrane to yield two daughter cells. Membrane proteins-many of the proteins involved in cell wall synthesis are membrane bound, including most of the penicillin receptors. Regulation of complex synthetic pathways-cell wall synthesis involves the interplay of large numbers of enzymes and is closely related as well to the synthesis of the other macromolecules in the cell. Penicillin provides a valuable tool for investigation of some of these problems.
Cell Wall Structure and Synthesis
The bacterial cell wall is a highly complex structure consisting of multiple classes of polymers. These polymers include the peptidoglycan, teichoic acids, attached and secreted polysaccharides or proteins, or both, and, in gram-negative organisms, lipopolysaccharide. The state of knowledge regarding these structures has been ably discussed in recent reviews, which cover cell walls in general (94, 174, 199, 208, 227) , peptidoglycan (83, 86, 93, 210, 217, 226, 244) , teichoic acids (4, 7, 8, 9) , and lipopolysaccharide (129, 136, 165) . Among these structures, the peptidoglycan is of particular importance. Its integrity is required for maintenance of cell shape in bacteria. Moreover, the peptidoglycan is the one cell wall constituent universally distributed in bacteria (except in extreme halophiles and in mycoplasma, both of which exist in very specialized environments), and, unlike most of the other cell wall polymers, it is essential for cell survival under normal growth conditions.
The precise composition of the peptidoglycan varies with the bacterial species. Typical struc-PENICILLIN INTERACTION WITH BACTERIAL CELLS tures are those shown in Fig. 2 . The peptidoglycan, also known as murein or mucopeptide, possesses a heteroglycan backbone of alternating residues of N-acetylglucosamine and Nacetylmuramic acid. The N-acetyl-muramic acid residues are substituted by peptide chains which are cross-linked to give a mesh-like character to the peptidoglycan. The net result is to knit the entire bacterial cell wall into a "bag-shaped macromolecule" (236) .
Synthesis of peptidoglycan can be divided conceptually into three stages (217, 218, 220) . The first step, catalyzed on the inside of the cell by cytoplasmic enzymes, is the synthesis of the soluble peptidoglycan precursor uridine 5'-diphosphate (UDP)-N-acetylmuramyl-pentapeptide (Fig. 3 ). This step is followed by transfer of the N-acetylmuramyl-pentapeptide and N-acetylglucosamine to a lipid carrier, C55-isoprenyl alcohol, in the membranes, forming a subunit of the glycan polymer (Fig. 4) . The membrane-bound disaccharide pentapeptide is now modified in a species-specific fashion. Such modification may include substitution of a carboxyl group on glutamic or diaminopimelic acid residues or attachment of a peptide side chain (e.g., the pentaglycine chain attached to the lysine residue of the pentapeptide in Staphylococcus aureus [ Fig. 4] ).
In the last stage, the modified disaccharidepentapeptide residue is transferred to a glycan acceptor on the outside of the cell to form linear peptidoglycan. Finally, the peptide chains of the linear peptidoglycan are cross-linked in a reaction catalyzed by a transpeptidase. It is this last step which is the penicillin-sensitive reaction in cell wall synthesis. The cross-bridge is formed between the carboxyl group of the pe- A nultimate D-alanine in the pentapeptide on one chain and an amino group in a nearby chain, for example, that of the diaminopimelic acid residue (Fig. 5a ). When a peptide cross-bridge is present, e.g., the pentaglycine chain in S. aureus, the amino group of the cross-bridge is used instead (Fig. 5b) . The driving force for the cross-linking is provided by release of the terminal D-alanine from the pentapeptide chain and probably by the insolubility of the cross-linked product. By using this transpeptidation mechanism, the organism avoids the energetic problem that would be involved in achieving net synthesis of peptide bonds outside the cell.
In some organisms, a D-alanine carboxypeptidase activity is present in addition to the transpeptidase. This activity, found in Escherichia coli and Bacillus subtilis but not in S. aureus, cleaves the terminal D-alanine from the pentapeptide chain of several different substrates. Its function is presently only conjectural. Because the tetrapeptide resulting from the action of the carboxypeptidase cannot function as a donor in transpeptidation, one hypothesis is that its function may be to decrease the amount of cross-linking in the cell wall of organisms possessing this enzyme.
Identification of the Target of Penicillin Action The effect of penicillin on cell wall structure and morphology has been known since the 1940s (59, 84, 85 ). Duguid's early analysis of the morphological effects showed great perspicacity (59) . He observed not only that penicillin required cell growth for activity, but also that cell death appeared to be caused by cell lysis: "The morphological changes produced by the lower penicillin concentrations . .. suggest that penicillin at these concentrations interferes specifically with the formation of the outer supporting cell wall, while otherwise allowing growth to proceed until the organism finally bursts its defective envelope and so undergoes lysis." A decade later, these observations had been con--Gly-Gly-Gly-Gly-Gly transpeptidase VOL. 38, 1974 295
on August 27, 2017 by guest http://mmbr.asm.org/ Downloaded from BLUMBERG AND STROMINGER firmed and extended by the finding that such penicillin-treated cells could be protected from the action of the antibiotic by the presence of an osmotic support, either sucrose or sodium chloride (97, 116, 117) . This result demonstrated a causal link between the observed changes in cell morphology, lysis, and cell death. Elucidation of the specific lesion in cell wall synthesis caused by penicillin followed from a different line of investigation. Early important observations were that labile esters, apparently containing reducing sugars (181) , and acid soluble absorbing materials, presumably free nucleotides (155) , accumulated in cells inhibited by penicillin. Determination of the structure of these nucleotide-sugar compounds (175) (176) (177) 216) revealed that they included UDP-N-acetylmuramyl-pentapeptide. This finding suggested that penicillin blocked a stage in cell wall biosynthesis subsequent to synthesis of this nucleotide precursor (182, 221) . These stages are now known to include both glycan polymerization and peptide cross-linking. Martin and co-workers (137) (138) (139) (140) in studying the composition of the peptidoglycan of the cell wall of Proteus mirabilis were led at first to the hypothesis that penicillin was inhibiting cross-linking, though later analyses led them to doubt their earlier conclusion (109) . Wise and Park (243) and Tipper and Strominger (228, 229) on the basis of different studies of the effects of penicillin on peptidoglycan synthesis in S. aureus concluded that the terminal reaction was a transpeptidation and that penicillin specifically blocked this reaction. (However, the generality of this conclusion has not been established).
This conclusion that penicillin blocked crosslinking was supported by in vitro studies. Transfer of sugar-peptide from nucleotide precursor to lipid and acceptor was not inhibited by large excesses of penicillin (33, 142, 143, 147) ; the sole remaining reaction which penicillin might inhibit in the biosynthetic sequence was thus transpeptidation. Finally, development of an in vitro transpeptidation assay permitted the direct demonstration of penicillin action (2, 105, 106) .
The model of transpeptidation and the proposed mode of action of penicillin which evolved from the above studies were as follows (222, 228, 229) (Fig. 6) .
Penicillin was hypothesized to be an analogue of the terminal D-alanyl-D-alanine in the pentapeptide chain (Fig. 7) . The CO-N bond in the highly strained beta-lactam ring would correspond to the peptide bond cleaved during transpeptidation, and penicillin might, in fact, be an analogue of the transition state in peptide bond cleavage. The transpeptidase would react with penicillin to split the beta-lactam ring to form a penicilloyl-enzyme complex, analogous to the postulated acyl-enzyme intermediate. However, since the penicilloyl-enzyme complex is stable, the transpeptidase would be inactivated (Fig.  6) .
The above brief description of cell wall synthesis does not emphasize the complexity of the phenomenon. Regulation of wall synthesis is tied into deoxyribonucleic acid (DNA) replication and the cell cycle. A specific cell shape is maintained during growth. The amount of wall synthesis is varied with the growth rate. The levels of degradative and synthetic enzymes are preserved in careful balance.
Recently, evidence of this complexity has begun to appear from several laboratories (219) . Multiple penicillin targets exist. How many are there? What are their relationships to each other and their roles in cell wall metabolism? Furthermore, the precise manner in which penicillin inhibits its various targets has never been fully elucidated. Is penicillin actually a substrate analogue or might it act at an allosteric site, as recently suggested (123) ? Does penicillin always act in the same way? The discussion which follows will examine the evidence regarding these questions.
PENICILLIN-BINDING COMPONENTS
Penicillin was first demonstrated to bind to bacteria in the late 1940s (50, 51, 134, 135, 203) . Its interaction with the cell has subsequently been studied in considerable detail (1, 6, 44-46, 49-51, 55, 58, 63-65, 67, 69, 75, 76, 110, 111, 113-115, 134, 135, 157, 160, 179, 185, 188, 189, 192, 197, 200, 202, 203, 209, 211, 225 ). An early discussion of the subject which showed great insight, but which is now out of date, is that of Cooper (48) . The goal of the penicillin-binding studies has been twofold, to elucidate the interaction of penicillin with the drug receptor(s) and to investigate the roles these receptors play in the metabolism of the cell. The state of understanding of both questions is still incomplete. However, the application of modern biochemical techniques has led to dramatic progress over the last few years. It has been possible to demonstrate multiple targets for penicillin. The roles of some of these targets have been identified. Furthermore, the penicillin-binding components have been isolated either as a mixture, or, for one of the components, in pure form. By using this material, the interaction of penicillin with its receptors has been shown to be much more complicated than previously believed.
The amount of penicillin which bacteria bind is very small. As a result, early efforts to detect the removal of penicillin from culture by bacteria were unsuccessful. Specific binding was obscured by the background loss of penicillin due to decomposition. Demonstration of binding therefore had to await the synthesis of radioactive penicillin, labeled in one of two ways. Early studies often used 35S-labeled penicillin produced biosynthetically by growth of the penicillin-producing mold in the presence of radioactive sulfate. The chief advantage of this material was its high specific activity, up to 300 mCi/mmol (209) . This permitted studies which would not have been possible with material of lower specific activity (209 What Is Actually Bound? In general, the entire penicillin molecule appears to react with its target, and a covalent bond appears to be formed between the carbonyl group of the beta-lactam ring and an unidentified group on the penicillin-binding components (PBCs) (see later section). In addition to this specific binding, certain penicillin degradation products may also bind to cells. Although no good comparisons have been published, cells appear to bind comparable quantities of penicillin regardless of whether the site of labeling of the antibiotic is in the side chain or in the drug nucleus (64, 114) . Further evidence that the entire molecule is bound comes from studies of the products liberated upon release of the penicillin bound to the binding components. The 35S-labeled compound released from the PBCs of M. pyogenes by alkaline treatment co-chromatographed with penicilloic acid (209) . Moreover, derivatives and degradation products of this material behaved chromatographically in the same way as did the comparable products arising from penicilloic acid. More recent studies with the membranebound PBCs of B. subtilis showed that the product of reversal by hydroxylamine cochromatographed with authentic penicilloyl hydroxymate in four solvent systems (114) . After reversal by ethanethiol and methylation with diazomethane, one of the two products cochromatographed with authentic a-ethylthio-flmethylpenicilloate (114) . The other had slightly slower mobility in all four solvent systems examined. The significance of this latter observation is not yet known.
The above conclusion that the entire penicillin molecule is bound ought not to be generalized to the case of cephalosporins, because it is known that hydrolysis of the beta-lactam bond of the cephalosporin leads to expulsion of the side chain in the 3-position (171) . A comparable reaction may occur after cephalosporin binding to PBC, but this matter has not been investigated.
An early question was whether the binding of radioactive penicillin which was observed was a property of the penicillin per se or whether it was due to an impurity in the radioactive material. The above work strongly implied that penicillin itself bound to the PBC (the penicilloic acid released by alkali from M. pyogenes presumably was a degradation product of the bound material, because penicilloic acid itself does not bind [49] ). Further evidence was that uptake of the radioactive material was prevented by prior addition of pure, unlabeled penicillin (45, 50, 157, 202) .
A characteristic of this specific uptake of radioactive penicillin was that after the PBCs became saturated, subsequent addition of radioactive penicillin had no effect on the amount of binding. However, in addition to this specific binding, a second binding phase was also sometimes observed, which was proportional to the amount of penicillin added and which could not readily be saturated. This second phase, unlike the specific uptake, was insensitive to such treatments as boiling of the PBCs. As shown by Cooper et al. and others (46, 49, 197) , such nonspecific binding was due to degradation products in the penicillin which accumulated with time; the nonspecific binding could be eliminated by repurification of the radioactive penicillin immediately before use. Although the identity of the penicillin degradation products responsible for such nonspecific binding has not been completely established, the most likely candidate is penicillenic acid. Unlike the other degradation products which Daniel and Johnson examined, penicillenic acid can compete for binding with radioactive penicillin (55) . Furthermore, it can also be shown to bind nonspecifically to proteins (55, 119) .
How Much Penicillin Do Cells Bind? Determinations of the amount of penicillin bound by bacteria vary with the growth state of the organisms, their treatment, etc. As a general rule, gram-positive organisms bind 4 to 15 nmol of penicillin per g (dry weight) (48, 225) . The gram-negative organism E. coli may bind 5-to 10-fold less. Such numbers correspond to 100 to 10,000 molecules of penicillin per cell (47, 64, 67, 134, 191, 225) ; the range of values commonly reported is 1,000 to 4,000 (64) .
The major uncertainty in these values lies in determinations of the number of cells per g (dry weight). For example, Suginaka et al. (225) and Rogers (197) both reported S. aureus H to bind specifically 5.7 nmol of penicillin per g (dry weight). However, the number of molecules per cell were reported as 4,000 and 100, respectively. In the first case, the number of cells was determined from a viable count. As recognized by the authors, this value may be low because clumps and chains of organisms are counted as a single organism. Rogers (149) .
A second cause for uncertainty, in the case of organisms which bind penicillin only at higher concentrations and in small amounts, is that the background arising from nonspecific binding may be substantial. E. coli, which binds one-tenth as much penicillin as does B. subtilis, is a typical example (225) . Here, 50% of the binding is nonspecific, and special care must be taken to determine the appropriate blank.
Is the Penicillin Bound Covalently? No general study has been made of bacterial proteins which bind penicillin tightly, but in a readily reversible fashion; the only work along such lines has been the analysis of cell wall enzymes which have later turned out to be reversibly inhibited by penicillins (see section on penicillin-sensitive enzymes). Instead, effort has concentrated on that firm penicillin binding which requires relatively drastic treatment for reversal. The evidence indicates that this binding is covalent. The nature of the covalent bond, however, is not certain.
Bound radioactive penicillin cannot be eluted from either whole cells or membranes by washing with nonradioactive penicillin (44, 64, 114, 134, 202) or released by treatment with penicillinase (114) . Conceivably the binding could be noncovalent, but very tight. However, proteindenaturing agents also do not induce penicillin release. Thus, treatment with sodium dodecyl sulfate (15, 16, 209 ) at 100 C, boiling (16, 46) , exposure to 8 M urea (16, 225) or 6 M guanidinehydrochloride (16) or phenol extraction (44, 202) have no effect. Evidence that such procedures actually do denature the PBCs is the ability of these treatments to prevent subsequent specific binding of radioactive penicillin. Similarly, Pronase digestion of the purified D-alanine carboxypeptidase-penicillin complex from Bacillus stearothermophilus did not release intact penicillin (16) . Further evidence for a covalent linkage of penicillin to the PBCs is formation of an a-ethylthio-penicilloate upon treatment of the PBC-bound penicillin with ethanethiol under conditions where the ethanethiol would not have been predicted to react with intact penicillin (114) .
To What Group Does Penicillin Bind? Early workers (209) believed that the penicillin might be bound as an ester because of its alkali lability. More recently the bond between the penicillin and the PBCs has been suggested to be a thioester, at least in the case of the B. subtilis binding components. The major evidence for this conclusion is the characteristics of reversal of the penicillin binding by various agents. In particular, hydroxylamine and H202 release penicillin under conditions where normal amide and ester linkages allegedly are not cleaved (114, 225) . Furthermore, treatment with ethanethiol is reported to lead to penicillin release (114, 225) . Consistent with this explanation, prior reaction of the PBCs with thiol reagents prevents the subsequent binding of radioactive penicillin (114) . In addition, with the purified D-alanine carboxypeptidase of B. subtilis, which accounts for 70% of the total penicillin binding in that organism (15) , binding of penicillin blocks one of the four sulfhydryl groups titratable with 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) (233) . Likewise, thiol reagents inactivate the enzyme (232) .
Although the above evidence is suggestive, it is by no means persuasive. The concentrations of thiol reagents employed to block binding by penicillin are grossly excessive. Whereas 1 mM iodoacetamide suffices to block normal sulfhydryl groups, Lawrence et al. (114) , for example, used 200 times more to prevent penicillin binding. At such concentrations, the reagent is no longer specific. Although the reason for the high levels of reagent which were necessary may be that the sulfhydryl group is deeply buried on the enzyme so that it is relatively inaccessible to the reagent, alternatively it may be that the alkylating reagent is reacting with a less readily alkylated residue than cysteine. Moreover, the ability of penicillin to protect a sulfhydryl group in the native enzyme from DTNB implies only that the group is in the penicillin binding site, not that it is covalently bound to penicillin. Furthermore, the hydroxylamine-induced release may be an enzymatically catalyzed reaction rather than a chemical hydrolysis (16) . Hydroxylamine release of the bound penicillin from B. subtilis membranes was prevented by boiling of the membranes after binding of the penicillin (114) . An initial interpretation was that the denaturing treatment rendered the penicillin-enzyme bond inaccessible to the hydroxylamine. More recent studies exclude this explanation. If denaturation is effected by agents which unfold proteins, e.g., sodium dodecyl sulfate, hydroxylamine still fails to bring about release (16 (114) . Tentatively, then, the conclusion is that a sulfhydryl group may be present in the penicillin binding site of the B. subtilis carboxypeptidase. This group may or may not be involved in covalent binding. Although a number of the experiments discussed above could be repeated and extended, the availability of purified enzymes and PBCs should permit a more definitive approach, viz, the isolation and characterization of peptides containing bound penicillin.
Under What Conditions Can Penicillin Be
Released from the PBCs? Specific release of penicillin from PBCs occurs upon treatment with H202, ethanethiol, and hydroxylamine as discussed above. The hydroxylamine treatment is of particular note because it does not destroy the ability of the PBCs to combine specifically with penicillin (14) . Similarly, in the case of the B. subtilis carboxypeptidase, hydroxylamine restored activity to the penicillin-inactivated enzyme (115) . This finding was crucial for the later development of covalent affinity chromatography as a means of purifying PBCs (described below) (14) .
Even more mild conditions may lead to release of penicillin and regeneration of enzymatic activities. During storage at 6 C in 0.05 M tris(hydroxymethyl)aminomethane-hydrochloride, pH 7.5, 1 mM MgCl2, 1 mM 2-mercaptoethanol, in the presence of penicillinase, enzymatic activity slowly returned to penicillininactivated D-alanine carboxypeptidase from B. subtilis. The rate was dramatically dependent on the penicillin derivative employed. Negligible activity returned when penicillin G or cephalothin was used. In contrast, the half-time for hydrolysis with cloxacillin was 68 h and with 6-aminopenicillanic acid was 14 h (13).
This phenomenon has subsequently been investigated in more detail (16) . The D-alanine carboxypeptidases from B. subtilis and Bacillus stearothermophilus both release their covalently bound penicillin. The rate of release varies with the organism, the specific penicillin derivative, and the temperature. At 37 C, the half-time of release of penicillin G is 200 min for the B. subtilis enzyme and 50 to 60 min for the B. stearothermophilus enzyme. The rate is highly temperature dependent. At 55 C, the half-time for release of penicillin G from the B. stearothermophilus enzyme is only 10 min. This release has the same pH optimum as the enzymatically catalyzed carboxypeptidase reaction.
The nature of the penicillin released by the enzyme is not known. It is neither benzylpenicillin, benzylpenicilloic acid, benzylpenilloic acid (the decarboxylation product of penicilloic acid), benzylpenicillenic acid (a rearrangement product of benzylpenicillin implicated in nonspecific binding), benzylpenillic acid (an acid-catalyzed rearrangement product of benzylpenicillin), nor phenylacetic acid (the penicillin side chain).
As was the case with the hydroxylamine release, the spontaneous release of penicillin would seem to be enzymatically catalyzed; release is prevented by denaturation of the enzyme. An important unresolved question is whether the enzyme simply labilizes the penicillin-enzyme bond, or whether it plays a more direct role, e.g., by transferring penicillin to acceptors such as hydroxylamine or ethanethiol. The determination of the structure of the material released from the enzyme hopefully may distinguish these alternatives.
Penicillinases long have been hypothesized to have evolved from PBCs (190, 228) . The (14) .
What Is the Physical Nature of the PBCs? The penicillin-binding components are proteins found either entirely or predominantly in the cell membrane. The binding components have been isolated from B. subtilis, S. aureus, and B. stearothermophilus by covalent affinity chromatography (14, 245) . In the case of the B. subtilis carboxypeptidase, only one of two purified PBCs studied in any detail, no lipid or carbohydrate covalently bound to the protein could be demonstrated (232) . The amino acid composition of the B. subtilis carboxypeptidase was relatively typical (232 (15, 245) . Such values are relevant to speculation on the origin of penicillinases, because the molecular weights of penicillinases with one exception-the R46 penicillinase-have been reported to be below about 30,000 (35, 36, 196) . Therefore, if the two classes of proteins are related, extensive deletion in the PBC gene must be postulated. Much evidence points to the PBCs being located in the membrane. Vigorous disruption of cells led to liberation of the PBCs into the cell supernatant (51) . However, if the cells were broken more gently, most of the PBCs remained in the bacterial cell wall fraction instead (75) . The difference in appearance of cell wall fractions in the two preparations suggested that, in the latter case, retention of the cytoplasmic membrane in the wall fraction was responsible for preservation of its penicillin-binding ability. This indeed appears to be the explanation. Pure walls do not bind penicillin (58) . Moreover, Cooper (45) showed that the distribution of PBC upon fractionation of cell lysates correlated with distribution of lipid phosphate. Furthermore, the specific binding activity of the lipid fraction was 7 to 12 times that of the whole organisms. Such a value is consistent with the PBCs all being located in the membrane. A difficulty in excluding the presence of a small fraction of soluble PBC was that a certain percentage of the membranes was not recovered during centrifugation. These contaminate the supernatant fraction and may account for the small amount of specific penicillin binding which Cooper reported finding in that fraction. Similar conclusions were reached by Suginaka et al. (225) . Within an experimental error of 20%, the same amount of penicillin was found regardless of whether penicillin binding to whole cells was measured, whether penicillin was first bound to the cells and membranes were subsequently prepared from them, or whether the membranes were prepared first and penicillin was then bound. As before, the qualification on these results is that the 20% experimental error could obscure binding by a biologically significant PBC in the cytoplasm. There is, however, no evidence for such an enzyme.
Little is known about the orientation of the PBCs in the membrane, viz, whether they are all on the outer surface or partly located on both surfaces. At least 50% of the D-alanine carboxypeptidase, the major binding component of B. subtilis, is on the outer surface (215).
This conclusion is based on the ability of penicillin covalently coupled to Sepharose to inhibit the enzyme in protoplasts. Because steric interference might be expected to prevent complete inhibition, the location of the other 50% cannot be inferred by this method.
Are PBCs Located in Peripheral Membranes, Mesosomes, or Both? Mesosomes are often attached to cell wall septa, which in turn are believed to be the major sites of cell wall synthesis (32, 70, 77, 206) . A possible prediction is that some or all PBCs might therefore be localized in the mesosomes. The evidence on this question is unfortunately both inadequate and conflicting.
Duerksen (58) reports that 95% of the label in cells of Bacillus cereus treated with radioactive penicillin was released upon conversion of the cells to protoplasts by treatment with lysozyme. Because mesosomes are released from the cell by such treatment, this finding would imply that the PBCs are located exclusively in the mesosomes. However, in the body of the paper, it appears that release of 58% of the label is a more typical value. Moreover, part of this material is dialyzable. It may be due to free penicillin trapped by the cell wall, hydrolysis of the penicilloyl-PBC bond, or proteolysis of the penicillin-PBC complex. The strongest statement that can be drawn from these findings is that a portion of the PBCs may be located in the mesosomes.
A similar conclusion was reached by Forsberg and Ward for distribution of the D-alanine carboxypeptidase of Bacillus licheniformis (80) . Here, the specific activity of this enzyme, the major PBC in those bacilli examined, was 65% as great in mesosomes as in peripheral membranes.
Do Organisms Have One or Multiple
Proteins Which Bind Penicillin? A major change in thinking about how penicillin acts on cells has been necessitated by the recent finding of multiple PBCs. The earliest evidence for multiple binding components was the suggestion of Mohberg and Johnson (157) that synnematin B (cephalosporin N) did not react with all the penicillin-binding sites of S. aureus which are sensitive to penicillin G. However, the evidence presented was weak. Competition experiments where radioactive penicillin G and nonradioactive synnematin B were added simultaneously indicated that a small portion of the penicillin sites (0.4 nmol/g of cells) were not subject to competition by 301 VoL 38, 1974 on August 27, 2017 by guest http://mmbr.asm.org/ Downloaded from BLUMBERG AND STROMINGER synnematin. Although the authors tried to exclude the possibility that this noncompetitive binding was due to penicillin degradation products, nonspecific binding still remains a probable explanation for their findings.
Much stronger evidence for multiple PBCs came by inference from the demonstration that the D-alanine carboxypeptidase of B. subtilis was distinct from the cephalothin killing site and was most likely not vital for cell metabolism (13) . In growing cells, exposure to low levels of cephalothin rendered the cells osmotically fragile under conditions where at least 85% of the carboxypeptidase activity remained. Conversely, exposure of growing cells to 6-aminopenicillanic acid could inhibit the carboxypeptidase 95% under conditions in which the growth rate of the organism was altered by 10% at most. These results implied the existence of two binding components, a cephalothinsensitive killing site (transpeptidase) and a relatively cephalothin-resistant carboxypeptidase. Whether separate proteins accounted for these sites or whether a single protein somehow was differentiated so as to exhibit these different behaviors was not determined.
Evidence for the former explanation, the existence of distinct proteins, was provided by Suginaka et al. (225) . Column chromatography and isoelectric focusing of solubilized membranes to which radioactive penicillin had been bound revealed multiple peaks of radioactivity. As discussed by the authors, the interpretation of these multiple peaks is unclear. Although they could represent separate proteins, they might also be artifacts caused by variations in charge or state of aggregation of a single protein. Indeed, the purified D-alanine carboxypeptidase from B. subtilis was subsequently shown to give multiple peaks upon isoelectric focusing in the presence of detergent (J. N. Umbreit, PH.D. thesis, Harvard University, Cambridge, Mass., 1972). Nonetheless, in the case of B. subtilis membranes, greatly different sensitivities to cephalothin of the bands found upon isoelectric focusing strongly argued for the existence of at least two distinct PBCs. The D-alanine carboxypeptidase would be among the cephalothinresistant bands; the killing site would presumably be among the cephalothin-sensitive bands.
Development of less ambiguous separation techniques greatly clarified the issue of multiple PBCs. Polyacrylamide gel electrophoresis in sodium dodecyl sulfate of solubilized membranes to which penicillin had been bound revealed multiple peaks-five in B. subtilis, three in B. cereus (or B. stearothermophilus (245)), and two in S. aureus (15) (Fig. 8, 9 ). For the B. subtilis components, the proportions, molecular weights, and kinetics of binding of penicillins and cephalosporins were determined (15) . Component V, which accounted for 70% of the total penicillin bound, was identified as the D-alanine carboxypeptidase. The evidence was that (i) it bound penicillins and cephalosporins at the same rate as did the carboxypeptidase and (ii) that it had the same molecular weight as the purified carboxypeptidase (232) . Three of the other components, I, II, and IV, were cephalothin sensitive. The rates of antibiotic binding of all three of these components were within a factor of three of that estimated for the penicillin killing site for the series of four beta-lactam antibiotics examined. Consequently, all three are candidates for the penicillin killing site.
The multiple PBCs revealed by SDS gels did not appear to be artifacts of the gel procedure (15) . Proteolysis was unlikely because the samples were boiled immediately after addition of the sodium dodecyl sulfate gel application buffer. Furthermore, treatment of the membranes with the protease inhibitor phenylmethane sulfonyl fluoride had no effect on the gel pattern. Aggregation caused by formation of disulfide bridges between proteins likewise seemed unlikely. Peaks eluted from gels and re-electrophoresed migrated with the same mobility as before, and the patterns obtained were quite reproducible from one experiment to the next. Further confidence in the validity of these results is provided by isolation of the PBCs by covalent affinity chromatography (14) .
Isolation of PBCs by Covalent Affinity Chromatography
The finding that neutral hydroxylamine could restore the activity of penicillin-inactivated D-alanine carboxypeptidase (115) and the development of convenient methods for coupling ligands to Sepharose (54) laid the stage for the isolation of PBCs by covalent affinity chromatography (14) . The affinity resin was prepared by coupling 6-aminopenicillanic acid via its free amino group to a long succinyldiaminodipropylamine side chain attached to Sepharose. Membranes were solubilized with nonionic detergent and then reacted with the Sepharose-linked penicillin. After penicilloylation of the PBCs had occurred, the unbound proteins were eluted by extensive washing of the Sepharose in the presence of high salt. The PBCs could then be recovered free from contaminating protein by elution with hydroxylamine.
In the case of B. subtilis, the same pattern of five components was obtained by affinity chromatography as had been found earlier upon electrophoresis of whole membranes to which radioactive penicillin had been bound. Because protein rather than radioactivity was being monitored, the protein could be reduced prior to sodium dodecyl sulfate gel electrophoresis. This finding eliminated the possibility mentioned above that some of the binding components Yields of the binding components were in general excellent. Carboxypeptidase was obtained in up to 80% yield. Those of components I, II, and IV were 50 to 110% of this. Component III, which bound penicillins quite poorly (15) , was obtained in much poorer yield, approximately 10%. The PBCs did not appear to be denatured by the isolation procedure. All still bound pencillin. For all components, approximately one molecule of penicillin appeared to have been bound per molecule of protein (12) .
Although the above procedure gave a mixture of five PBCs, a minor modification permitted purification of the B. subtilis carboxypeptidase (Fig. 10) . If the membranes were treated with low levels of cephalothin before addition of the Sepharose-linked penicillin, binding to the affinity resin of the cephalothin-sensitive components , II, and IV was blocked. Only components III and V were therefore contained in the hydroxylamine eluant from the affinity column. The customary low yield of component III in the affinity chromatography step, together with further loss during concentration of the eluant from the affinity column, reduced the level of contamination of the carboxypeptidase to less than 1%. Because the carboxypeptidase is a major membrane protein (15, 232) , 0.75% of the total protein in the membrane, this procedure has now made available for study a PBC in quantities of the order of hundreds of milligrams. In addition, the procedure has also been applied for purifying the D-alanine carboxypeptidase from the thermophilic organism B. stearothermophilus (245) .
A possible criticism of the demonstration of multiple PBCs in B. subtilis is that conceivably the multiplicity of components could have arisen from proteolysis of the binding component of highest molecular weight. Such a suggestion seems most unlikely. The proportions of the components are relatively constant. The rates at which they bind penicillins are dramatically different, up to four orders of magnitude.
The carboxypeptidase, the component of lowest molecular weight, has a unique N-terminal amino acid. Nonetheless, although nonspecific proteolysis seems very unlikely, the possibility of specific proteolysis cannot be excluded. Proinsulin is converted to insulin, trypsinogen to trypsin. Such a process could be involved in control of cell wall synthesis. Comparison of the tryptic maps of the isolated binding components would resolve the matter in a straightforward fashion. Affinity chromatography on a cephalosporin C column has also been used as one step in a purification of the penicillinase from B. licheniformis (52) . In that case, however, the enzyme is not covalently linked to the column and is eluted by a change in the pH of the buffer. What Is the Relationship of the PBCs to the Killing Site? Tremendous effort has been devoted to study of the PBCs on the assumption that analysis of the PBCs may lead to a better understanding of the interaction of penicillin with its killing site. However, despite considerable effort, the relationship between PBC and killing site is still indeterminate. Basically, for a variety of wildtype organisms, the sensitivity to penicillins of the PBCs correlates with the sensitivity of the whole organisms. On the other hand, in penicillin-resistant mutants isolated in the laboratory, the resistance of the organisms is not reflected by the PBCs.
Early observations that penicillin-sensitive staphylococci bound penicillin whereas resist- In a more recent study, mutants of S. aureus H resistant to up to 105 times the penicillin concentration lethal for the parent strain were isolated (179) . They still bound large amounts of penicillin at very low penicillin concentrations (0.1 Ag/ml for some) although, in fact, the amounts were only 50% of that bound by the parent. The authors hypothesize an explanation for their data in terms of (i) "functional versus nonfunctional transpeptidase molecules," (ii) "variations in accessibility to penicillin," and (iii) substrate protection of transpeptidase.
A study by Sabath et al. (207) sheds further light on the problem. Strains of S. aureus 104 times more resistant to methicillin than the wild type were isolated. The pH of the medium had a dramatic effect on this resistance. At pH 5.2 the resistance was not expressed. In contrast, pH had little effect on the sensitivity of the wild-type organism to the antibiotic. The interpretation is that this "intrinsic resistance" shown by the mutants is due not to an alteration in the target enzyme, but to a change in its accessibility. A similar situation may exist in the mutants isolated by Park et al. (179) .
The conclusion that can be drawn from the above studies with mutants is that the situation is quite complex. The results can well be explained by the presence of multiple PBCs, only some of which are lethal targets for penicillin. In such cases, binding by the nonlethal target may obscure the relevant reaction. This possibility had in fact been considered as one explanation for the results (65) . At that time, the techniques were not available to test the hypothesis. A second possibility is that some portion of the PBCs may be maintained in a cryptic state. If a cryptic site were the killing site and if penicillin binding to it could be observed only, for example, after disruption of the cells, then detection of alterations of it in mutant cells would not be observed by the techniques ordinarily used. A third possibility, which cannot be ignored, is that none of the PBCs may be the lethal target in some microorganisms. (197) examined the effect of prior binding of penicillin followed by removal on the total amount of peptidoglycan synthesized (he did not look at the degree of cross-linking). He found that prior reaction with penicillin greatly sensitized the amount of total cell wall synthesis to inhibition upon readdition of penicillin. He interpreted this and other results to indicate that most of the penicillin binding in S. aureus was not important, but that a small number of sometimes cryptic penicillin-sensitive sites played a vital role.
The second study (179, 180) showed that cells of S. aureus grown in the presence of penicillin showed subsequent inhibition of the total amount of cell wall synthesized. Moreover, although experimental details were not given, exposure of cells in buffer to penicillin followed by washing of the cells led to partial inhibition of cell wall cross-linking. This latter result would suggest that one of the PBCs is a transpeptidase in this organism.
In this sort of experiment direct and indirect effects of the penicillin treatment must be differentiated. If cells become "sick" during the penicillin treatment, the subsequent effect on cell wall synthesis may reflect this disturbance rather than the irreversible binding of the penicillin. Moreover, peptidoglycan synthesis and cross-linking are different phenomena; the role of the PBCs in these two processes may well be different. Finally, results in S. aureus cannot be generalized either to gram-positive bacilli or to gram-negative organisms.
PENICILLIN-SENSITIVE ENZYMES
The above discussion deals with one approach to the study of the mode of action of penicillins, namely, the analysis of proteins which irreversibly bind beta-lactam antibiotics. The discovery that penicillin inhibited cell wall biosynthesis led to a second line of investigation in the study of the enzymatic activities involved in cell wall metabolism and their sensitivities to penicillins. As was the case with the PBCs, cell wall enzymology has turned out to be far more complex than had initially been believed. In all, three different penicillin-sensitive enzymatic activities have now been reported. Several major issues in the field at the present time can be defined. (i) What relationship do the different enzymatic activities have to each other? Are they catalyzed by the same or separate enzymes? (ii) How many proteins (enzymes) in a given organism catalyze any one of these activities? (iii) What is the function of the different types of penicillin-sensitive enzymes? (iv) What relationship do the different activities have to the mode of killing by penicillin; which one or ones are the killing site? (v) How does penicillin interact with these enzymes?
The different penicillin-sensitive enzymatic activities found in bacteria include (i) transpeptidases, assayed either with natural or with artificial acceptors; (ii) D-alanine carboxypeptidases; and (iii) endopeptidases, enzymes which cleave cross-linked peptide dimers of the peptidoglycan. Of these activities, the first is of particular interest because penicillin is thought to kill bacteria by inhibiting peptidoglycan cross-linking.
Transpeptidase
Transpeptidase assayed with natural acceptor in a coupled system. This first assay most closely approximates the in vivo transpeptidation reaction. After addition of substrate, UDP-acetylmuramyl-pentapeptide, the reaction proceeds through the complex series of polymerization steps which culminate in peptide cross-linking and release of the terminal D-alanine from the pentapeptide chain (Fig. 3,  4 , and 5). Although for many years such a system had only been demonstrable with the gram-negative organisms E. coli and Salmonella (2, 3, 105, 106), similar reactions have now been carried out with B. megaterium (239, 240) , Micrococcus luteus (152), S. aureus (154), Sporosarcinia ureae (128) , and B. stearothermophilus (127) .
The course of the reaction can be monitored by release of the C-terminal D-alanine from the pentapeptide. The reaction product is applied to paper and chromatographed in isobutyric acid-1 N ammonia (5:3) to separate substrate, degradation products, newly formed peptidoglycan, and liberated D-alanine. Under optimal conditions, D-alanine release is coupled to peptidoglycan cross-linking; 1 mol of D-alanine is released per mole of acetylmuramyl-pentapeptide incorporated into the peptidoglycan. Analysis of the reaction products confirms the occurrence of cross-linking. Lysozyme digestion of the products leads to the release of dimers of disaccharide-peptide. In contrast, if cross-linking is prevented by penicillin, only monomers of the disaccharide-peptide can be obtained.
Several factors seem relatively important in obtaining an in vitro peptidoglycan synthesizing system of the sort described above. First of all, simplicity in the cell wall structure is a major advantage. Because the coupled system requires the activity of all those enzymes functioning in the biosynthetic pathway beyond the level of the UDP-acetylmuramyl-pentapeptide, each modification of the pentapeptide which is required for eventual cross-linking reduces the chances of success. Thus, the two best-studied peptidoglycan-synthesizing systems are in E. coli and B. megaterium, neither of which has modifications of the basic pentapeptide structure in its peptidoglycan. Conversely, in B. subtilis, where the carboxyl group of the diaminopimelic acid residue of the pentapeptide is amidated (235), it has not been possible so far to demonstrate in vitro cross-linking, although synthesis of linear peptidoglycan can be obtained (115) . The existence of modification reactions is not an insuperable barrier, however. Recently cross-linking has been demonstrated both in a system from B. stearothermophilus which includes an amidation reaction (127) and also in the even more complicated system in S. ureae (128) , where the addition of glycine and D-glutamic acid in the cross bridge precedes cross-linking.
A second important factor is a fairly low level of autolytic and other degradative enzymes. For example, although autolysins cause only minor problems in assays with E. coli, they cause rapid breakdown of the newly formed peptidoglycan in B. subtilis (115) . Degradation of the substrate must also be avoided. D-Alanine carboxypeptidases release the terminal D-alanine from UDP-acetylmuramyl-pentapeptide, rendering it incapable of acting as a donor in transpeptidation. As a further drawback, this D-alanine release by the carboxypeptidase can obscure the specific D-alanine release catalyzed by the transpeptidase. In such cases, the extent of transpeptidation must be monitored by the more laborious procedure of lysozyme digestion followed by analysis of dimer formation. Thus, transpeptidation is far more readily assayed in E. coli K-12, which has low levels of D-alanine carboxypeptidase, than in E. coli B, which possesses high levels (105, 106) .
Thirdly, the gentle preparation of the appropriate membrane fraction is critical. Different means of breakage can affect specific activities by more than a factor of ten (193, 194, 239) . Grinding with glass beads is apparently fairly gentle; rupture in a French press is more severe (193) . Furthermore, the membrane fractions composed of larger membrane pieces appear to be more active (154, 193) . Presumably, excessive fragmentation of the membrane leads to disorganization of the enzyme system. In accord with this general concept, complete peptidoglycan synthesis was obtained in what was essentially the cell wall fraction of S. aureus and M. luteus (152, 154) . It was suggested that the membrane attached to the cell wall might be precisely that active at the growing points for new cell wall synthesis.
The different transpeptidase activities assayed by means of the coupled cross-linking reaction have all proved to be penicillin sensitive. However, although the E. coli (3, 105, 106 ), S. aureus (154) , and M. luteus (152) systems are irreversibly inhibited by penicillins (i.e., the transpeptidases presumably are PBCs), this result cannot be generalized. The transpeptidase of the B. megaterium system is reported to be reversibly inhibited by penicillins (239, 240) . In this organism, therefore, the transpeptidase may not be a PBC.
Transpeptidase assayed with unnatural acceptor in a coupled system. A major difficulty inherent in any coupled reaction as an assay for transpeptidase is that it cannot be used to assay fractionated membranes. Consequently, it cannot provide an assay useful for purification. From this point of view, transpeptidation reactions utilizing simpler unnatural acceptors are potentially of more value.
Two such reactions have been described. In B. megaterium, inclusion of a D-amino acid at moderately high concentration in the peptidoglycan synthesizing system leads to incorporation of the D-amino acid into the newly synthesized peptidoglycan (239, 240) . Analysis of the products revealed that the D-amino acid (diaminopimelic acid was used customarily) was incorporated via a transpeptidation in the normal fashion. Because the enzyme recognized the D-center of the amino acid, dimer formation occurred in the presence of DD-diaminopimelic acid, which possesses two such centers. The products formed are shown in Fig. 11 .
This system, although slightly simpler than the normal transpeptidation assay, is still a coupled system. The simultaneous presence of the diaminopimelic acid during synthesis of linear peptidoglycan is required. The activity is penicillin sensitive. Of the inhibition, about one-half is reversible. The rest is irreversible (see later section).
Transpeptidase assayed in a simple, uncoupled system. An important development has been the demonstration of transpeptidase reactions catalyzed by purified D-alanine carboxypeptidases from Streptomyces spp. (60, 89-92, 184, 186) and B. stearothermophilus (195, 245) . These assays employ synthetic and natural peptides which function in an uncoupled system both as donors and acceptors in the reactions. These activities were discovered in enzymes which were first isolated as D-alanine carboxypeptidases and have given rise to extensive discussion of the physiological functions of such "DD-carboxypeptidase transpeptidases." They are discussed below together with the carboxypeptidases.
D-Alanine Carboxypeptidase In addition to the transpeptidases, a second penicillin-sensitive activity which has attracted considerable attention is that of the D-alanine carboxypeptidases, first encountered in E. coli (2, 105) . These enzymes specifically hydrolyze the peptide bond between the two terminal D-alanine residues of UDP-acetylmuramyl-Lala-D-glu-meso-Dap-D-ala-D-ala (Fig. 12 ). So far, carboxypeptidases which utilize the corresponding L-lysine-containing substrate have not been identified. Upon its discovery, it was postulated that the D-alanine carboxypeptidase might be an "uncoupled" transpeptidase (105, 115) , where water rather than an amino group displaced the enzyme from the postulated acylenzyme intermediate (see Fig. 12 ). Other possi- Table 1 . Because these enzymes are the only penicillin-sensitive enzymes which so far have been purified to homogeneity, they have been the object of most of the detailed study of the interaction of penicillin and substrates with penicillin-sensitive enzymes.
E. coli carboxypeptidase. The soluble E. coli carboxypeptidase has only been partially purified (107) . Unlike the other carboxypeptidases, it may have a requirement for the nucleotide moiety of its substrate; the enzyme is only 20% as active on acetylmuramyl-pentapeptide as on UDP-acetylmuramyl-pentapeptide (107) . This reduction in activity may or may not be an artifact of metal ion concentration. The enzyme also stands out for its sensitivity to penicillins.
Penicillin G at a concentration of 0.002 gg/ml causes 50% inhibition.
Carboxypeptidases from Bacillus. The B. subtilis carboxypeptidsase by contrast is located in the membrane and has been purified to homogeneity by two procedures: by conventional enzyme purification techniques after solubilization in detergent (231, 232) and by covalent affinity chromatography (14) . The enzyme has been extensively studied both as a PBC and as a penicillin-sensitive enzyme. Unlike the E. coli carboxypeptidase, it does not appear to recognize the nucleotide portion of its substrate, because it possesses comparable activity on UDP-acetylmuramyl-pentapeptide and acetylmuramyl-pentapeptide (115) . In addition, the B. subtilis enzyme can cleave the synthetic substrate N,N-diacetyl-lysyl-D-alanyl-D-alanine used to assay the Streptomyces enzymes (see below). The B. subtilis carboxypeptidase displays intermediate sensitivity to penicillins.
It is inhibited by 0.3 Aig/ml of penicillin G (13). However, it is only inhibited by 150 jg/ml of cloxacillin.
The B. stearothermophilus carboxypeptidase resembles the B. subtilis enzyme in most respects. It is distinguished, however, by its unusual temperature stability. It should be noted that its purification by covalent affinity chromatography, at least as reported, is less satisfactory than that of the B. subtilis enzyme. The low increase in specific activity suggests that partial inactivation of the enzyme may occur during purification. Like the Streptomyces carboxypeptidases discussed below, the B. stearothermophilus enzyme can carry out a single transpeptidation reaction by using UDP-acetylmuramyl-L-ala-D-glu-meso-Dap-Dala-D-ala as donor and glycine or D-alanine, but not diaminopimelic acid, as acceptor (11, 195) (Fig. 12) . At an acceptor-donor ratio of 100:1, the percentage of donor transpeptidated was greater than 60%. Indeed, at a 1:1 ratio of D-alanine to donor, 5% transpeptidation still occurred.
Streptomyces carboxypeptidases. The Streptomyces spp. apparently secrete into the Table 2 . Determination of carboxypeptidase activity on an extensive series of synthetic peptides of the general structure X -R, -R2 -R1 (OH) reveals certain substrate requirements of the enzymes (120, 121, 123) :
(i) The C-terminal amino acid (Rj) should be a free acid, although there is some activity with the amide. This residue must be either glycine or else a D-amino acid. The specificity for the D-amino acid is relatively low.
(ii) The R2 residue should be D-alanine. There is some activity with glycine, but none with other D-or L-amino acids. The strictest specificity occurs at this residue.
(iii) The R, residue must be an L-amino acid and substituted on its a-amino group, i.e., X cannot be a hydrogen atom. It should also possess a long side chain. Thus, R, cannot be hydrogen or acetyl, i.e., D-alanyl-D-alanine and acetyl-D-alanyl-D-alanine are not substrates. For some strains, namely Streptomyces albus G, K11, and R61, any additional terminal amino group on the side chain of R, (e.g., on lysine) should be acylated. For strain G, but not R61, the enzyme is also active if this amino group is in an a position to a free carboxyl group (e.g., as in diaminopimelic acid). In contrast, with the R39 enzyme, acylation of the amino group reduces the activity. For all four enzymes, substitution of the e-amino group of lysine at R, with pentaglycine gives a highly active sub- Peptide analogues of the N,N-diacetyl-Llysyl-D-alanyl-D-alanine function in some cases as competitive inhibitors of the albus G and R61 enzymes (164) . Such studies suggest that the two C-terminal residues of the tripeptide function to promote binding to the enzyme. The third residue has little effect on binding. Rather, the side chain is crucial for promoting catalytic activity. In addition, it has been suggested that the normal configuration of the peptide bond in the C-terminal dipeptide during binding to the enzyme is cis. This conclusion is based on one observation: that the acetylracemic-cyclodiaminoadipic acid lactam acts as a relatively good inhibitor of the R61 and albus G enzymes. This compound is an alanyl-alanine analogue, constrained to a cis configuration by its ring formation. These conclusions ought not be generalized to the R39 enzyme. This enzyme was not inhibited by any of the peptide inhibitors examined; indeed, some of the peptides were good substrates for the enzyme.
(i) Transpeptidase activity with amino acid acceptors: In addition to D-alanine carboxypeptidase activity, the R39, R61, and K11 enzymes, but not the albus G enzyme, also possess transpeptidase activity. This activity was first shown by using N,N-diacetyl-L-lysyl-D-alanyl-D-alanine as donor and D-alanine or glycine as acceptor (186) . In the presence of acceptor, three reactions occurred. Donor was cleaved by the carboxypeptidase activity, donor was transferred to acceptor, and the transpeptidation product was cleaved by the carboxypeptidase activity. The proportion of donor converted to transpeptidation product under optimal conditions was quite high, greater than 60% for either R61 or R39 at an acceptor to donor ratio of 100: 1 (i.e., 0.15 M acceptor). At lower acceptor-donor ratios, the amount of transpeptidation which occurred was still substantial: At 10:1, it was 55 and 40% for the R61 and R39 enzymes, respectively. Indeed, 5% transpeptidation still occurred with the R61 enzyme at a 1:125 ratio.
Several factors affected the relative activities of the enzymes as transpeptidases and carboxypeptidases. High pH favored transpeptidation (82, 89, 92) . Likewise, a 50% reduction in water content in the assay mixture by ethylene glycol and glycerol (65:35, vol/vol) decreased hydrolysis of donor tripeptide considerably, from 60 to 25%, while having little effect on transpeptidation. In addition, as will be discussed below, high concentrations of transpeptidation acceptor not only enhanced transpeptidation but often decreased hydrolysis of donor by a greater amount than could be explained by competition between hydrolysis and transpeptidation.
(ii) Transpeptidase activity with dipeptide acceptors: The structure of the cell wall of Streptomyces strains R61 and K11 differs from that of strain R39 (which indeed suggests that strain R39 may have been improperly classified as Streptomyces [89] ). Whereas the crossbridge in the former strains extends through LL-diaminopimelic acid and glycine, that in the latter is a direct linkage via meso-diaminopimelic acid (see Table 2 ). In accord with this difference in cell wall structure, the acceptor specificity for the R61 and K11 enzymes differs from that of the R39 enzyme. Although both the R39 and R61 enzymes could use as acceptor the amino acids glycine, D-alanine, and meso-diaminopimelic acid, only the R61 enzyme was active with a wide range of compounds (184) . Dipeptides with N-terminal glycine were most active. Those with N-terminal D-alanine were less so. Good acceptors had a C-terminal amino acid which neither was too bulky nor possessed a D-asymmetric center in the group involved in the peptide bond. Thus, the best acceptors were either glycyl-L-alanine, glycyl-glycine, or E-glycyl-L-lysine. Perhaps a little surprisingly, a-glycyl-a'-acetyl-LLdiaminopimelic acid, the analogue of the natural acceptor in the cell wall, gave four-to fivefold less transpeptidation than the above acceptors. A large number of other acceptors also functioned with the R61 enzyme. These included the lactam of meso-diaminopimelic acid, 2-amino-2-deoxyhexuronic acid, D-cyclOserine, and 6-aminopenicillanic acid (a poor acceptor).
(iii) Transpeptidase activity with cell wall peptides as acceptors: The use of natural cell wall peptides as acceptors for the R61 enzyme has not been reported. However, although dipeptides did not function as acceptors for the R39 enzyme, analogues of the natural cell wall peptide acceptor were active (89) . Here, specificity was directed at the tripeptide sequence
acid. Substitution either of the N-terminus with the disaccharide f-1,4-N-acetyl-glucosaminyl-N-acetylmuramic acid or else of the C-terminus with D-alanine had little effect. In contrast, amidation of the a-carboxyl on the glutamic acid or of the D-carboxyl on the diaminopimelic acid residues had profound effects. The latter substitution rendered the compound completely inactive. The former converted it to the natural cell wall tetrapeptide in this organism and caused major changes in its influence on hydrolysis and transpeptidation. Transpeptidation by using natural amidated donor as well as accep- tor has not yet been reported. However, at high concentrations of peptide, the R39 enzyme does catalyze dimer formation between two molecules of the pentapeptide L-alanyl-'y-D-glutamyl-L-meso-diaminopimelyl-D-alanyl-D-alanine (92) . This peptide differs from the one naturally found in the wall only in its lack of amide substitution on the a-carboxyl of the glutamic acid.
Multiple observations indicated that the nature and concentration of the acceptor affected the efficiency of the R39-enzyme both as a carboxypeptidase and as a transpeptidase (89) . (i) With L-alanyl-y-D-glutamyl-(L)-mesodiaminopimelic acid as acceptor, increasing the concentration of acceptor above a 9: 1 acceptor to donor ratio had no further effect on the extent of transpeptidation. It did, however, considerably decrease the extent of donor hydrolysis. (ii) Amide substitution of the a-carboxyl of the glutamic acid in the above tripeptide acceptor caused transpeptidation to occur only within a narrow range of acceptor-donor ratios (1 to 3: 1 was optimal, depending on the donor concentration used). Higher ratios strongly inhibited both transpeptidation and hydrolysis. (iii) The semiamidated peptide dimer (Fig. 13) did not itself serve as an acceptor. However, it strongly inhibited both the carboxypeptidase activity of the R39 enzyme and also its transpeptidase activity with glutamic-amidated tetrapeptide as acceptor.
Basically similar although less extensive evidence exists for such effects by acceptor on the R61 enzyme (82, 184) . High concentrations of dipeptide acceptor inhibited both transpeptidation and donor hydrolysis. The relative sensitivity of the two processes depended on the specific acceptor examined. When diaminopimelic acid was used as acceptor instead, no such inhibition occurred.
In addition to the purified soluble DD-carboxypeptidase-transpeptidase discussed above, Streptomyces R61 also possesses a similar membrane-bound transpeptidase activity (60, 92) . This activity differs from that of the soluble enzyme in that in the membrane it acts exclusively as a transpeptidase. Carboxypeptidase activity appears, however, upon solubilization of the activity in 2 M urea, 10 mM ethylenediaminetetraacetic acid. In addition, the membrane activity differs from that of the soluble enzyme in the efficiency of transpeptidation obtained with different acceptors, being more efficient with some substrates and less efficient with others. Endopeptidase Several endopeptidases have been found in E. coli (17, 98, 183) . These enzymes cleave the disaccharide-tetrapeptide dimer between the D-alanine and the diaminopimelic acid residues (Fig. 14) . Such endopeptidases thus act as autolytic enzymes which antagonize the action of the transpeptidase. At least one endopeptidase activity in E. coli is penicillin sensitive (17); a second activity unaffected by the antibiotic has also been reported (98) .
It has been noted that the endopeptidase substrate formally resembles that of a D-alanine carboxypeptidase, in that both possess a free carboxyl group in a position alpha to the peptide bond which is cleaved. The free COOH group in the cross-linked dimer is that on the D-asymmetric center of the diaminopimelic acid residue (Fig. 14) . In agreement with this resemblance in substrate, the B. stearothermophilus (245) , Streptomyces (82, 120, 123) , and E. coli (17) carboxypeptidases also possess endopeptidase activity. The levels of activity as endopeptidases are less than as carboxypeptidases, however. The relative enzymatic efficiencies range from 17 to 0.15%.
Other Activities
The presence in E. coli of a "penicillin sensitive glycosidase" was also reported (98; J. V. HiSltje, Ph.D. thesis, Eberhard-Karls Universitat, TUbingen, Federal Republic of Germany, 1970). However, the degree of sensitivity of this enzyme to penicillin is not very great. The data show that penicillin at 1,000 U/ml (600 gg/ml) inhibits 20%; at 2,500 U/ml (1, 500 ,gg/ml), it inhibits 40%. These values are sufficiently high so that the specificity of the reaction with penicillin is questionable. Because the enzyme apparently is very labile, bovine serum albumin is added for stabilization. The authors attempt to explain the relative insensitivity of the enzyme to penicillin in terms of a nonspecific interference with the action of penicillin by the bovine serum albumin. However, the validity of this explanation is dubious. Halobacterium salinarium lacks the peptidoglycan characteristic of normal bacteria (112) . Nevertheless, the organism has been reported to be sensitive to relatively high concentrations of penicillin (158) . This finding suggests that penicillin may be able, at high concentrations, to inhibit some activity other than those with which it is normally associated. (Table 4) .
Number of Enzymes
In the S. aureus transpeptidase system (154), transpeptidation is inhibited 60% by penicillin G at 0.5 ,ug/ml. The remaining synthesis is considerably more refractory. Half-inhibition requires perhaps 25 ,g/ml. This result might imply two separate transpeptidases in this organism (possibly corresponding to the two PBCs in S. aureus).
In E. coli, the transpeptidase is irreversibly inhibited (106, 107) . Moreover, the sensitivity of the carboxypeptidase to penicillins is at least 100 times greater than is that of the transpeptidase. These enzymes therefore are presumably different. Carboxypeptidase and endopeptidase in E. coli have been suggested to be the same on the basis of their simultaneous presence in a partially purified carboxypeptidase preparation (17) . Further purification, however, suggests that the situation is more complex. Multiple activity peaks were found on column chromatography. At least three types of enzyme were present, having (i) carboxypeptidase activity only, (ii) endopeptidase activity only, and (iii) both types of activity (224) .
In Streptomyces, as discussed elsewhere, the soluble and membrane-bound transpeptidases probably differ. Among other evidence, the two enzymes show dramatically different profiles of sensitivity to various penicillins (60, 90) . Likewise, the D-alanine carboxypeptidase of B. subtilis appears to differ from the penicillin killing site, presumably the transpeptidase (13). On the other hand, multiple activities are possessed by several purified enzymes. The purified Streptomyces R61, K11, and R39 carboxypeptidases (82, 89, 92, 184, 186) and the purified B. stearothermophilus carboxypeptidase (245) also exhibit "transpeptidase" and endopeptidase activity.
Much of the above evidence for the existence of multiple enzymes is susceptible to different interpretations. In cases where activities are partially inhibitable, the assignment of multiple enzymes is least convincing. Because the assays are customarily performed on heterogeneous membrane preparations, differences in the location of the enzyme in the membrane could result in shielding of a certain proportion of the sites from penicillin. Likewise, artifacts in the determination of penicillin inhibition could generate the appearance of separate enzymes (see later section). Moreover, if penicillin acted as an allosteric inhibitor, complete binding might result in only partial inhibition of a homogeneous enzyme.
Another consideration is that some change in state or structure of one enzyme with one pattern of antibiotic sensitivities might lead to a new activity with a new pattern of interaction with penicillins. If the active site of a transpeptidase became accessible to water, it might be converted to a carboxypeptidase. The kinetics of penicillin inhibition might also be altered. Such an effect has been assumed (60, 92) to account for the difference in penicillin sensitivities of the soluble and particulate transpeptidases of Streptomyces. However, this hypothesis remains unproven.
To the contrary, the purified B. subtilis carboxypeptidase closely resembles the membrane-bound, unpurified enzyme; penicillin sensitivities for the enzyme in the two states agree with each other within a factor of two (233) . A possibly more significant type of alteration could be proteolytic degradation. Because the molecular weight of the B. subtilis carboxypeptidase is only 40% of that of the PBC of highest molecular weight (I), removal of 60% of component I could easily change the protein sufficiently to account for the difference of up to 104 in the reactivities to various penicillin derivatives.
Consequently, separate important questions are: (i) How many distinct proteins account for the assayable activities? (ii) How many genes code for these distinct proteins? The answer to the second question will require mutants defective in the different enzymes or structural comparison of the purified, distinct proteins.
Relationship of the Penicillin-Sensitive
Enzymes to the PBCs The demonstration of multiple penicillin-sensitive activities is in accord with the existence of multiple PBCs. Both lines of evidence support the general conclusion that at least some of the multiple enzymatic activities are real rather than artifacts of assay. S. aureus may have two distinguishable transpeptidase activities. It likewise has two binding components. B. subtilis and B. stearothermophilus have cephalothin-sensitive killing sites and a cephalothinresistant carboxypeptidase; they similarly possess both cephalothin-sensitive and cephalothin-resistant PBCs.
The binding components of E. coli have not been thoroughly investigated. However, in unpublished experiments at least two have been shown to exist. PBCs have not been analyzed in Streptomyces.
The demonstration in B. megaterium that the cross-linking activity is reversibly inhibited by penicillins while some other activities are irreversibly inhibited is very important. It emphasizes that the penicillin killing site may not be a PBC. Furthermore, it underlines the dangers in generalizing results from one class of bacteria to another.
Physiological Functions of the Penicillin-Sensitive Enzymes
The physiological role of no penicillin-sensitive enzyme has been determined in a convincing fashion. The most thorough study has been devoted to the carboxypeptidases. The cell walls of organisms possessing carboxypeptidases show a relatively low degree of cross-linking. The peptidoglycan of E. coli or B. subtilis is cross-linked to form dimers or trimers at most. In contrast, the peptidoglycan of an organism such as S. aureus, which lacks a carboxypeptidase, is much more highly cross-linked. Because the product of the carboxypeptidase reaction is incapable of being a donor in cell wall crosslinking, the function of the enzyme may be to regulate the degree of linkage in the wall. An alternative hypothesis is that the carboxypeptidase activity is a side reaction of the transpeptidase.
Evidence against this latter hypothesis is the demonstration that cephalothin kills B. subtilis without inhibiting carboxypeptidase. (213) . Several factors may account for these results. (i) Five percent of the carboxypeptidase activity may be sufficient for the cell. This enzyme is present, after all, in much larger quantities in B. subtilis than are the putative transpeptidases. (ii) Only a small fraction of the total carboxypeptidase may function in cell wall synthesis. After residing only momentarily at the site of peptidoglycan synthesis, the enzyme might be displaced and become functionally inactive. Because the resistance of the enzyme to penicillins should be inversely proportional to its half-life (13), the physiologically relevent carboxypeptidase would be much more resistant than predicted. (iii) This putative small fraction of carboxypeptidase at the growth zone might be inaccessible to the penicillin and thereby protected.
Technically, the accuracy of the experiment suffers from the use of dinitrophenylation of unblocked amino groups on the diaminopimelic acid to determine the degree of cross-linking. If the effects on cross-linking were small, they might have been obscured by experimental error. More accurate determination should be possible with a recently developed technique, deamination of the free amino groups by nitrous acid (78, 153) .
In E. coli, the carboxypeptidase is reversibly inhibited by penicillins. Consequently, although the Ki for the enzyme is considerably below the concentration required to kill the cells, inhibition of the enzyme in intact cells cannot be verified. Indeed, the enzyme may not be accessible to penicillin. Much of it is cytoplasmic, and it is not clear either that penicillin penetrates the cytoplasmic membrane or that it does not suffer interference from the high protein concentration in the cytoplasm.
The properties of the E. coli enzymes support the suggestion that the carboxypeptidase could regulate cross-linking. The enzyme is five times more active on the soluble precursor UDPacetylmuramyl-pentapeptide than it is on the acetylmuramyl-pentapeptide alone (107) . On uncross-linked cell walls, even less activity could be shown. Moreover, it has been shown that the UDP-acetylmuramyl-tetrapeptide which results from the action of the carboxypeptidase can be incorporated into linear peptidoglycan (106) . Experimental questions which would be of interest to answer are (i) whether UDP-acetylmuramyl-tetrapeptide is present in appreciable amounts in E. coli and (ii) whether the ratio of UDP-acetylmuramyl-tetrapeptide to UDP-acetylmuramyl-pentapeptide is affected by penicillin.
The membrane-bound transpeptidase assayable in Streptomyces R61 (60, 92) is quite plausibly a killing site for penicillin. The enzyme and organism differ by no more than a factor of five in their sensitivities to penicillin. Whether other potential lethal targets for penicillin exist in this organism is not known.
The role of the soluble DD-carboxypeptidase-(endopeptidase)-transpeptidase in Streptomyces is more of a puzzle. It is excreted into the medium and, unlike the case of the membranebound transpeptidase, there is no correlation between its sensitivity to different penicillins in strains R39, R61, and K11 and that of the organism. Moreover, whereas certain peptide analogues of the substrate inhibit this enzyme, they are not inhibitory for the organism (164) . Likewise, no transpeptidase activity can be demonstrated in one of the "DD-carboxypeptidase-transpeptidases," that from Streptomyces albus G. Consequently, the soluble carboxypeptidase itself would appear to be distinct from the physiological transpeptidase.
The question arises, however, whether this enzyme could be a solubilized form of the membrane-bound transpeptidase. Inadequate evidence exists to resolve this question, although it has been stated without qualification that the two enzymes are related (60) . The strongest evidence against the hypothesis is the disparity in penicillin sensitivities of the two enzymes (see preceding section). Likewise, the enzymes differ somewhat in the extent of transpeptidation they can perform with different acceptors (see earlier section). On the other hand, the membrane-bound transpeptidase upon solubilization of 2 M urea acquired some carboxypeptidase activity. Moreover, the specificity for acceptors, particularly for the R39 enzyme and the kinetics of inhibition of transpeptidation at high acceptor concentrations (82, 92) strongly suggest that the carboxypeptidases possess an acceptor binding site.
Most known membrane enzymes, except for those which have been solubilized by proteolysis, are water soluble only in the presence of detergent. If the membrane-bound transpeptidase of Streptomyces is related to the soluble carboxypeptidase-transpeptidase found in the culture medium of these organisms, it seems a strong possibility that the latter may be a 317 Voi -38, 1974 on August 27, 2017 by guest http://mmbr.asm.org/ Downloaded from BLUMBERG AND STROMINGER proteolytic fragment of the former. This possibility is perhaps strengthened by the fact that maximal activity in the culture filtrates from which the carboxypeptidases were prepared was obtained only after 50 to 135 h of incubation (87, 120, 123 ). An important, related question is whether the release of these enzymes from the cells is by chance or whether it is the result of a specific process. If it is a specific process, then what physiological function does the enzyme have for the organism?
The presence of a binding site for acceptor on the enzyme would be compatible either with a proteolytic origin for these enzymes or with an evolutionary origin from a transpeptidase gene. Alternatively, if the physiological function of the enzyme is neither as transpeptidase nor as carboxypeptidase, but rather as endopeptidase, then it would need to possess binding sites for both the "donor" and "acceptor" portions of the cross-linked dimer substrate. Studies of the carboxypeptidase from Streptomyces have already contributed to our knowledge of enzymes of cell wall metabolism, and resolution of the questions raised surely will significantly enhance our understanding of this interesting biochemical process.
If indeed there are two transpeptidase activities in S. aureus (see earlier section), they may not both be needed for cell survival. This possibility is one interpretation which could be drawn from the report (180) that highly penicillin-resistant S. aureus mutants still bound penicillin at low concentrations. This binding would have to be to the more sensitive of the two putative transpeptidases, because binding was accomplished with penicillin at a concentration of 0.1 gg/ml. However, it has not yet been shown that the two S. aureus binding components correspond to two transpeptidase activities, nor has the sensitivity of the separated PBCs in the mutants been reported.
In B. megaterium, the transpeptidase activity assayed with diaminopimelic acid as acceptor may be essential to the viability of the organism but, if so, it is not the most sensitive vital target for the action of beta-lactam antibiotics. Cephalosporins such as 7-aminocephalosporanic acid and cephalothin killed cells at concentration at which little inhibition of the transpeptidation assayed with diaminopimelic acid as acceptor occurred (12% inhibition in the case of the 7-aminocephalosporanic acid) (240) . The crosslinking activity, in contrast, showed better, although not excellent, agreement.
In E. coli, the cross-linking activity has the sensitivity to ampicillin, cephalothin, and methicillin expected for the killing site (217) . Although the enzyme is 10-fold more sensitive to penicillin G than is the whole organism, this difference is attributed to the relative impermeability to this antibiotic of the outer membrane of E. coli. Although this explanation is probably correct, it should be noted that E. coli K-12 may be more permeable to penicillin G than ampicillin (196) . The physiological role of the endopeptidase of E. coli has not been studied.
The study of transpeptidase activities in different organisms clarifies both their role in the cell and their relationship to the killing site. First, multiple transpeptidases seem to exist. Consequently, the assay of one, as is the case in either E. coli or Streptomyces, does not indicate without supporting evidence that it is either the only transpeptidase activity in that organism or that it is the killing site. If multiple transpeptidases are found, inhibition of merely the most sensitive enzyme may be lethal. Alternatively, inhibition of the most resistant may be necessary. This latter possibility would help explain results such as those found by Park et al. (180) . Resistance of the second component would be obscured by the continued sensitivity of the first. Physiological Evidence for the Existence of Multiple Transpeptidases The biochemical results agree with the physiological evidence that led to the initial hypothesis that multiple transpeptidases exist (212, 219, 225) . In E. coli, low concentrations of penicillin are known to cause filamentation (59, 84, 85) . Higher concentrations may inhibit elongation as well (212) . With a penicillin-resistant mutant of B. licheniformis, conversely, elongation was inhibited by nonlethal concentrations of penicillin (99) . In addition, structural differences apparently exist between cell walls from the ends and sides of the rod-shaped bacterium B. subtilis as evidenced by differential sensitivity to autolytic enzymes (73, 74) . Moreover, intrinsic resistance to penicillin, unlike that to such drugs as streptomycin, is acquired only in a stepwise fashion (56, 57) .
Separate transpeptidases could function for cell wall elongation, for septum formation, and for corner formation in rod-shaped organisms. This hypothesis would provide a rationale for the multiple PBCs (14, 15) and transpeptidase activities. Likewise, it would account for the inability to obtain mutants resistant in a single step to a high level of penicillin. If three transpeptidases had sensitivites of x < y < z, 
Kinetics of Penicillin Inhibition
A variety of kinetic mechanisms for inhibition of different enzymes by penicillins have been described. In some cases penicillin acts as a reversible, competitive inhibitor. The soluble E. coli carboxypeptidase, which is inhibited in this manner, is extraordinarily sensitive to penicillins (107) . Representative K1 values are 1.6 x 10-8 M for penicillin G, 6 .4 x 10-M for ampicillin, and 3 x 10-6 M for cephalothin. Penicillins which either lacked the side chain, viz., 6-amino-penicillanic acid, or which had a hydrolyzed beta-lactam bond. viz., penicilloic acid, still retained some activity. The Ki values of those compounds were 2.5 x 10-6 M and 5 x 10-6 M, respectively.
The second common type of inhibition is irreversible inactivation caused by covalent binding of the penicillin to the enzyme. This mode of action is exemplified by the B. subtilis carboxypeptidase (13, 233) . Here, the reaction between penicillin and enzyme is believed to occur in a two-step process.
K,
The penicillin binds to the enzyme in a reversible complex; irreversible inactivation, probably by acylation of the enzyme, follows. For such a reaction In (active enzyme per total enzyme) = -k3.P-t/(K, + P). (2) The values for k. and K, have been determined for 10 beta-lactam antibiotics (233) . The sensitivity of the carboxypeptidase to inhibition appeared to depend primarily on its K, for the particular beta-lactam antibiotic. Values ranged from 28 to 0.1 mM. In contrast the rates of acylation, k,, were relatively constant, 42-2 x 10-2 s-1. The actual numbers should be viewed with some caution, however. The values of k,3
correspond to one-half of the enzyme being converted from E-P to EP* in 1.7 to 35 s. Such times are of the same order as those required for mixing, degradation of free penicillin by penicillinase, etc. Indeed, the data plotted to determine K, and k3 do not distinguish beyond doubt between the postulated mechanism and the simplistic model E + P -EP* (3) although the two-step mechanism is in all probability correct.
In any case, the concentrations of beta-lactam antibiotics customarily employed when measuring rates of binding are far below their K, values (reversible) for the enzyme. Consequently, the rate of inhibition can be approximated as In (active enzyme per total enzyme) = -klPP*PP-t (4) where kapp = (kIK,). For the one-step mechanism (equation 3), an identical relation would hold, where kapp , = ka.
Briefly, equation 4 indicates that inactivation of the enzyme by acylation is proportional to time as well as to penicillin concentration, provided that the penicillin concentration is sufficiently greater than that of the enzyme, so that it remains constant over the course of the reaction. Consequently, when irreversible inactivation takes place, discussion of enzyme sensitivity merely in terms of penicillin concentration is relatively meaningless. Rates of inactivation are most easily determined by first binding penicillin to the enzyme for a fixed amount of time, then destroying free penicillin with penicillinase, and finally assaying residual enzymatic activity.
Although inhibition of carboxypeptidase in vitro is proportional to the exponential of the penicillin concentration, inhibition of the enzyme in growing cells is proportional to the concentration instead (13):
active enzyme per total enzyme (5) 1 + kaps * PP generation time.
The explanation is that in growing cultures the enzyme is being synthesized exponentially as well as inactivated exponentially. The combination of the two effects yields a nonexponential term dependent on the ratios of the relative rate constants.
The kinetics of irreversible inactivation have been demonstrated only with the carboxypeptidases from B. subtilis and B. stearothermophilus (13, 233, 245) . Here, it was also confirmed that the inactivation of the enzyme was accompanied by the physical binding of penicillin (15, 232) . Inhibition of a number of other enzymes, including the E. coli (106) and M. luteus (152) transpeptidases, is not reversed by penicillinase; but the kinetics of binding have not been studied, and there is no direct proof for the assumption that they are acylated.
The carboxypeptidases isolated from the penicillin-sensitive strains of Streptomyces R61 and K11 were inhibited by penicillin in a competitive manner (120, 123) (but see below). However, that from strain R39 appeared to have been inhibited in a partially competitive fashion (123) . The kinetics were mistakenly termed "noncompetitive" in the paper. As plotted, the data in fact show that both Vmax and Km were altered in the presence of penicillin. Moreover, additional data points would be desirable, because lines indicating strictly competitive inhibition might be drawn through the points illustrated. If in fact both Km and /max were altered, the binding of penicillin at the substrate site might distort the enzyme so as to result in a decrease in its catalytic efficiency (Vmax). Such a phenomenon has been seen in the inhibition of penicillinases by some penicillins. Other possible problems are that approximately comparable distortions in kinetics would have been obtained if penicillin were causing irreversible inactivation of the enzyme (cf. 233), although the possibility of such inactivation was rendered fairly unlikely by extensive controls. Likewise, reversible inactivation would lead to similar distortions, provided that release of bound penicillin occurred slowly. Although the rate of release has not been reported for the R39 enzyme, for the R61 enzyme it is very slow, with a half-time of several hours (see below). Some hydrolysis of penicillin due to instability under the conditions of assay could have led to a distortion of the kinetics. Consequently, the nature of the inhibition of the R39 enzyme must be considered unresolved. However, confirmation that inhibition is partially competitive and an explanation of the phenomenon would be of major importance in shaping thinking about the nature of the interaction of penicillin with its receptors.
An additional type of inhibition which may occur is irreversible inhibition that is not accompanied by irreversible binding of penicillin. After inhibition of the D-alanine carboxypeptidase of E. coli by penicillin G, only 66% of the enzymatic activity was restored by addition of penicillinase (107) . Although the authors suggest that penicilloic acid might account for the residual inhibition, this does not appear to be the case. The penicilloic acid concentration should only be 0.008 jg/ml; 50% inhibition of the enzyme by penicilloic acid only occurs at 2 jig/ml, a concentration 250-fold higher. Likewise, because the E. coli carboxypeptidase does not bind penicillins irreversibly (114) , models involving partial binding or hydrolysis are unlikely. One alternative which has precedent in a related system is that the presence of penicillin may convert the enzyme to a particularly labile state, in which it then proceeds to denature. Such a phenomenon occurs when the S. aureus penicillinase is exposed to methicillin (35, 36, 96) . Moreover, as has been shown recently, penicillin binding renders the Streptomyces R61 enzyme more readily denaturable (92) .
Irreversible inhibition is not always irreversible (see earlier section). Release of penicillin G from the B. subtilis D-alanine carboxypeptidase at 37 C occurs with a half-time of 200 min (16) . At 55 C, release from the B. stearothermophilus carboxypeptidase is even faster (half-time of 10 min). Because the incubation period for assay of enzymatic activity is often long compared with these release times, misleading kinetic results can be obtained. In the case of the B. subtilis carboxypeptidase, 6-aminopenicillanic acid caused partial inhibition at low concentrations. Very much higher concentrations did not inhibit the remaining activity (115) . This result suggested the existence of two carboxypeptidases, one sensitive to 6-aminopenicillanic acid and the other resistant. In reality, there is only one enzyme. The "resistant fraction" was an artifact of release of 6-aminopenicillanic acid during the course of the assay.
Such artifacts do not account for the partial reversibility of the inhibition by penicillin of the transpeptidase activity assayed with diaminopimelic acid as acceptor in B. megaterium. Unlike the above example, the proportion of activity in the B. megaterium system which was reversible was independent of the length of time for which the penicillin-inhibited enzyme was exposed to penicillinase before assay (240) . If hydrolysis were occurring, a greater proportion of the activity would appear to be reversible at later times.
In B. subtilis, the kinetics of penicillin binding to the PBCs I, IV, and V were those predicted for irreversible binding (15) . However, the binding curve of component II was biphasic for certain penicillins, viz., 6-aminopenicillanic acid and penicillin G. The reason for this behavior is not yet known. A trivial explanation is that there were actually two proteins in the component II peak obtained on sodium dodecyl sulfate polyacrylamide gels. However, this possibility seems unlikely in that the components would have needed identical molecular weights and rates of binding for a number of penicillins, and they would have had to be present in equal amounts. Other possibilities are either negative cooperativity in penicillin binding or else a difference in the accessibility to these penicillins unique to component II. where E = enzyme, P = penicillin, EP = penicilloylated enzyme, and P* is the unidentified produce of release. Provided that P >> E (so that the decrease in the concentration of P as it is converted to P* can be neglected), then in the steady state (E)(P) = 2= K,.
(EP) k, An apparent K, can thus be determined. (233) and B. stearothermophilus (16) carboxypeptidases are acylated, the kinetics of inhibition are competitive with respect to substrate. Thus, the existence of competitive kinetics in the absence of supporting data does not suffice to distinguish between mechanisms involving covalent and noncovalent inhibition.
The necessity for caution is emphasized by the behavior of the Streptomyces R-61 carboxypeptidase. Penicillin binds to this enzyme slowly (accompanied by a conformational change in the enzyme). Penicillin is also released very slowly (half-time of 145 min) (92, 163) . The reaction scheme is E+P= =EP KD= * Models for the Interaction ofPenicillin with Its Target A number of models have been proposed which suggest an analogy between penicillin and various portions of the peptidoglycan. Before it was known that penicillin inhibited cross-linking, Collins and Richmond proposed that penicillin G was an analogue of N-acetylmuramic acid (43) . The subsequent demonstration of the effect of penicillin on transpeptidation deprived this hypothesis of much of its attraction. Subsequently, Wise and Park argued that penicillin was an analogue of the L-alanyl-y-D-glutamyl portion of acetylmuramylpentapeptide (243) . However, this hypothesis was rendered unlikely by the finding that the a-carboxyl of the glutamate in the pentapeptide of S. aureus was amidated.
Tipper and Strominger (228) proposed that penicillin was an analogue of the terminal acyl-D-alanyl-D-alanine in the pentapeptide chain (see Fig. 7 ). More specifically, the fixed ring structure common to penicillins was hypothesized to be a structural analogue of that conformation of acyl-D-alanyl-D-alanine which binds to the active site of the enzyme. In this model, the reactive CO-N bond in the highly strained beta-lactam ring would correspond in position to the peptide bond cleaved during transpeptidation and would be ideally situated to react with the acyl acceptor site of the enzyme. The two rings of the penicillin nucleus are in different planes, and it was further hypothesized that penicillin might more strictly be an analogue of a transition state during cleavage of the normal peptide substrate, at which the planar double-bond character of the peptide bond had deteriorated into a nonplanar single-bonded state. Reaction of the transpeptidase with the beta-lactam ring of penicillin would result in formation of a penicilloyl enzyme complex analogous to the postulated acyl enzyme intermediate and would provide a rational explanation for the acylation of PBCs by beta-lactam antibiotics. The idea that penicillin was a transition state analogue was further explored by Lee (118) . (16) . Such a reaction could best be explained if penicillin were bound at the catalytic site of the enzyme.
Although the most likely explanation is that both penicillin and substrate are bound at the catalytic site on the enzyme, containing an active sulfhydryl group, the data are also compatible with an alternative model in which the sulfhydryl is at an allosteric site. In this latter case, competition would be due to alternative conformational states of the enzyme (catalytically active and inactive) induced by substrate or penicillin. Experimentally, these possibilities can be distinguished by demonstrating that substrate and penicillin are bound at the same site (e.g., by affinity labeling or by isolation of the hypothetical acyl enzyme intermediate) or by crystallographic studies of the enzyme with substrate or inhibitor bound, both difficult objectives.
In addition, the substrate analogue hypothesis predicted that 6-methyl-penicillins and 7-methyl-cephalosporins, which would more closely resemble the D-alanyl-D-alanine, might be even better antibiotics than the unmodified molecule (228) . This prediction has not been supported by experiment either in vivo (18, 102) or in vitro (240) . However, the 7-methoxy substituents on cephalosporins result in highly active antibiotics which also are active in vitro as inhibitors of the penicillin-sensitive enzymes (102, 150, 151, 214) . Thus, before the relationship of these data to the proposed mechanism can be evaluated, it is important to know why two bulky substituents on the beta-lactam ring (methyl and methoxy) have such different effects on activity. There are presently insufficient data relating to this point to evaluate it further. One important consideration may be the effect of different substituents on the reactivity of the beta-lactam ring.
The alternative hypothesis that penicillin may exert its control at an allosteric site on the enzyme is based on studies of the Streptomyces DD-carboxypeptidase-transpeptidases. Several experimental observations led to this hypothesis. (i) Inhibition of the R39 enzyme by penicillin is partially competitive rather than competitive (123) . ( ii) The binding of penicillin to the R61 enzyme, monitored fluorimetrically, can be competed with neither acceptor nor donor (92) . (iii) Penicillin apparently binds to the R61 enzyme under conditions where the enzyme is partially denatured and inactive (viz., in 3.6 M guanidine-hydrochloride) (163) . (iv) The albus G carboxypeptidase is insensitive to inhibition by penicillins, but it is inhibited by synthetic substrate analogues (122, 164) .
None of the above arguments is persuasive. (i) The unusual kinetics reported for inhibition of the R39 enzyme may have several explanations, which have been discussed above. (ii) The claim that transpeptidation donor cannot compete for binding with penicillin to the R61 enzyme, determined by physical measurements (92, 163) , is inconsistent with the kinetic measurements that donor and penicillin do compete (120). It is not clear from the published data whether the amount of substrate present (5 x Ki) would have been sufficiently high to compete with inhibitor. (iii) The binding of penicillin to inactivated enzyme does not indicate that the substrate and drug-binding sites are different. Rather, it implies that sufficient damage to the enzyme has occurred so that certain catalytic functions are lost. Substrate may also bind to the partially denatured enzyme. (iv) The failure of penicillin to inhibit the S. albus G carboxypeptidase suggests only that this enzyme has a stricter binding site than the other enzymes. In fact it has the lowest Km for substrate of all of the Streptomyces carboxypeptidases. An analogous case may be dihydropteroate synthetase in sulfonamide-sensitive and -resistant bacteria. Sulfonamides are structural analogues of p-aminobenzoic acid, a substrate for this enzyme. In the resistant organisms, sulfonamides, the substrate analogues, bind to the enzyme much more poorly, but the binding of substrate itself is unaffected (172, 173) . There are some obvious differences in some of the bond angles in substrate and penicillin. If penicillin is an analogue of the transition state of the terminal D-alanyl-D-alanine, and not of the ground state, it might fail to bind to a substrate binding site which required an unusually specific fit. Inhibition of this enzyme by synthetic substrate analogues which closely resemble substrate is compatible with this concept. It indicates that certain peptide analogues, such as substrate itself, can fit the binding site of this particular enzyme, something which the putative transition state analogue cannot do. On the other hand, penicillin binds to the penicillin-sensitive o-alanine carboxypeptidases of E. coli and Streptomyces strains R61, K11, and R39 much better than does substrate: the values of K, for penicillin G are 1.6 x 10-8 M, 7.5 x 10-M, 6 x 10"8M, and 1.4 x 10-8 M, respectively. The values of Km are 0.6 mM (UDP-acetylmuramyl-pentapeptide as substrate), 12 mM, 11 mM, and 0.8 mM (N,Ndiacetyl-lysyl-D-alanyl-D-alanine as substrate), respectively. This result, that inhibitor binds much better than substrate, is characteristic of transition state analogues (124) .
The behavior of the D-alanine carboxypeptidase from B. stearothermophilus membranes was interpreted to provide further support for the allosteric model of penicillin action (11) . First, penicillin gave only partial inhibition of the membrane activity, 75 to 80%. This partial inhibition was reflected in hyperbolic plots of Km/V. Secondly, certain treatments, e.g., storage at 4 or -20 C, led to apparent partial dissociation of penicillin sensitivity from enzyme activity. In general, the partial loss of enzymatic activity was accompanied by disproportionately greater loss of the ability of penicillin to inhibit the enzyme. For example, storage at -20 C for 4 weeks led to 61% loss of activity, but only 10% of this remaining activity could be inhibited by penicillin. Consequently, the absolute penicillin-resistant activity had increased from 20% of the original total to 34.6%. Similarly, after storage for 3 weeks at 0 C, the membrane activity had decreased to 43%. It remained 80% inhibitable by penicillin. However, if after storage the membranes were resuspended and sedimented by centrifugation, then the penicillin sensitivity was lost.
The authors interpreted these complicated results to indicate that penicillin bound to "at most only a portion of the catalytic site," or, alternatively, that it acted as an allosteric inhibitor. The possibility that there were two D-alanine carboxypeptidases, which differed in stability at 4 and -20 C and one of which was penicillin insensitive, was considered, although deemed unlikely. The authors argued that this model could not explain the increase in the total penicillin-resistant activity which occurred upon storage.
The behavior of the purified D-alanine carboxypeptidase of B. stearothermophilus (albeit from a different strain) provides no evidence for dissociation of activity and inhibition (245) , and this purified enzyme is totally inhibitable by penicillin. Consequently, the presence of two carboxypeptidases and possible artifacts associated with the membrane location of the unpurified enzymes may account for the anomalous results reported (11) . Several D-alanine carboxypeptidases are known to occur in both E. coli (224) and B. megaterium (240) , and in the latter case one of these is penicillin insensitive.
If penicillin is a substrate analogue, then the active sites of carboxypeptidases can be divided into two classes according to whether acylation occurs or does not occur. (i) In the one studied example of the first class (B. subtilis), penicillin forms a weak reversible complex (K, = 10-2 to 10-4 M) with the enzyme. Significant inhibition results because of acylation. (ii) In the second class, penicillin binds very tightly (K1 = 10-8 M), but does not acylate. The large difference in the values of K, in the two cases suggests one possible explanation for the occurrence or lack of acylation. In the first class, it is possible that the penicillin must be distorted to bind to the enzyme, hence the high K1. This strain energy sufficiently activates the beta-lactam bond to induce acylation of an active group at the binding site of the enzyme, probably but not necessarily the same one involved in formation of the putative "acyl enzyme intermediate." In the second class, penicillin might fit the configuration of the active site much better. Because the molecule remains undistorted, acylation would not occur. Alternatively, of course, these two types of carboxypeptidases may have evolved with two different mechanisms, the second class having no acylation in either its mechanism or its inhibition. In other proteases, they are obviously examples of those which utilize covalent intermediates and those which do not (21) .
Thus, there are at the present time two theories for the mode of inhibition of bacterial enzymes by penicillin-the substrate analogue hypothesis and the allosteric inhibitor hypothesis, neither of which is supported by substantial data. It has been shown that some bacterial enzymes at least are inhibited by an acylation mechanism and that some catalytic activities (transfer of pencilloyl to hydroxylamine and release of penicillin in an altered form) occur at this site, but it has not been decisively shown that this is the same site at which catalysis of substrate occurs. The protection by substrate against penicillin inactivation and the protection of a sulfhydryl group from inactivation by substrate are most simply interpreted by this model, but these facts are also compatible with other models. The possibility that penicillin may act at an allosteric site derives in part from the idea that there must be regulatory mechanisms in cell wall synthesis and that penicillin could be an analogue of some natural regulator (19 (156) . More detailed characterization of the D-alanine carboxypeptidase mutant should prove illuminating. Several other mutants, which accumulate UDP-acetylmuramyl-pentapeptide and in which no enzymatic defect has been found so far, may also be of considerable interest.
A related, but more direct, approach for isolating mutants defective in the penicillinsensitive enzymes of E. coli has recently been attempted (108) . Because penicillin-resistant mutants were generally caused by alterations in permeability or penicillinase, whereas lysis mutants were generally altered in the wrong enzyme, a double-selection method was used. Mutants were isolated which were simultaneously penicillin-resistant at low temperature and lytic at high temperature. The reasoning was that a certain proportion of the mutations which rendered vital penicillin-sensitive enzymes resistant would simultaneously render the enzymes temperature labile. Most of the mutants which became resistant due to changes in permeability or penicillinase would presumably not lyse and could be discarded. By means of this technique, 500 mutants were isolated. Of these, a number possessed either hypo-or hyper-cross-linked peptidoglycan. Further characterization of these mutants is in progress.
Evidence That Penicillin Kills by Inhibiting
Cross-Linking Penicillin is believed to kill bacteria by inhibiting peptidoglycan cross-linking. However, the only thorough studies that this is the mechanism of killing in vivo have been carried out in S. aureus (228, 229, 243) . Here, good correlation was shown between killing by penicillin and inhibition of cross-linking. Likewise, penicillin inhibits cross-linking of B. megaterium cell wall in vivo (78) . Whether this inhibition correlates well with killing has not yet been reported.
In the presence of penicillin, Proteus mirabilis is converted to spherical forms (Lforms) which are viable in the presence of sucrose. These L-forms are able to grow and multiply and initially can revert to bacilli upon removal of penicillin. The peptidoglycan composition of these penicillin-induced L-forms of P. mirabilis was similar in composition to that of the wild type (138, 139) . However, whereas the L-form cell wall was completely broken down by lysozyme, that of the parent rod was only partially degraded. This result led H. H. Martin to suggest that "penicillin ... prevented the formation of certain cross-linkages within the mucopolymer which are indispensable for the establishment of shape and mechanical stability." Later studies from the same laboratory cast doubt on this conclusion (109, 137) . Incomplete digestion by lysozyme, rather than the presence of additional cross-linking, was found to account for the reduced breakdown. Moreover, in both parent and L-form, 32 to 34% of the diaminopimelic acid residues in the cell wall were susceptible to dinitrophenylation, i.e., there was no difference in cross-linking. If the effect of penicillin on P. mirabilis is due to an effect on cross-linking, it would have to be due to an effect on an extremely localized region of the wall, e.g., an effect on the enzymes responsi-ble for the synthesis of the corners of the rod (cf. earlier section). Likewise, no change in the cross-linking of the cell walls of E. coli grown in the presence of penicillin was observed in the one case where this has been studied (212) .
In view of the great differences which exist between bacteria both in their PBCs and in the enzymes which they possess, which are sensitive to penicillin, generalization of the results obtained in S. aureus is obviously not justified. In vitro and in vivo studies in the bacilli and in vitro studies in E. coli are consistent with the lethal action of penicillin being inhibition of cross-linking. However, it is possible in these cases that the inhibition of cross-linking is a subsidiary reaction which occurs in addition to the actual action of the antibiotic.
A still unexplained effect of penicillins on peptidoglycan synthesis in B. megaterium could be a clue to an additional mechanism (240) . When in vitro peptidoglycan synthesis was inhibited by concentrations of cloxacillin just sufficient to prevent cross-linking, two unidentified lysozyme digestion products were formed which possessed mobilities greater than those of known disaccharide-peptides. The amounts produced were very large, up to 65% of the total peptidoglycan synthesized. At only fivefoldhigher concentrations of cloxacillin, the amount of these products decreased dramatically to 20%o. What relation these products bear to the killing action of cloxacillin is not known.
Killing by Amidino Penicillin Indeed, a new class of penicillins, amidino penicillins, have a mode of killing different from that of normal penicillins. The basic structure of this class of derivatives is shown in Fig. 15 . The distinguishing feature is the replacement by an amidino linkage of the usual acylamino linkage attaching the side chain. The effect of the drug was striking in that gram-negative organisms such as E. coli were up to 100 times more sensitive than were such gram-positive organisms as S. aureus or B. subtilis. In the case of a typical penicillin derivative, ampicillin, the ratio is just the opposite. Furthermore, E. coli treated with low concentrations of amidino penicillin formed large spherical bodies which slowly lysed, regardless of whether sucrose was present or not. Ampicillin-treated cells, in contrast, form small spheroplasts which are protected by sucrose, but which lyse instantly if the osmotic support is removed (133, 148) : At high concentrations of the amidino penicillin, E. coli is lysed in the same manner as by ampicillin.
It thus appears that amidino penicillin functions poorly as a penicillin which inhibits crosslinking. However, there must exist some other enzymatic activity in gram-negative organisms which is lacking in gram-positive organisms and which is exquisitely sensitive to the amidino penicillin. The effects on cell morphology make it likely, although not certain, that the inhibited activity is related to envelope synthesis. One possible candidate might be the enzyme which attaches the lipoprotein (22-27, 100, 101, 104, 141) to the peptidoglycan, presumably by a transpeptidation. Recent work lends credence to this model (145, 178) . E. coli transpeptidase, carboxypeptidase, and endopeptidase were not inhibited by lethal concentrations of amidino penicillin. High concentrations of amidino penicillin had no effect on the binding of ["4C ]penicillin G to E. coli membranes. Mutants resistant to the amidino penicillin showed no cross-resistance to normal penicillin.
Transfer of Penicillin Side Chain Studies of the binding to gram-positive organisms of penicillins labeled in either the side chain ("4C) or nucleus (35S) indicated that both portions of the molecule were bound to the PBCs (see earlier section). However, several papers suggest that the problem should be re-examined in gram-negative organisms. E. coli possesses an amidase which cleaves the side chain from the penicillin nucleus (5, (39) (40) (41) (42) 192) . The activity of this amidase may be considerable, up to fourfold greater than that catalyzed by the penicillinase of the organism. A correlation has been reported between the activity of penicillins against E. coli and the susceptibility of the penicillins to the amidase (110); the highly active penicillins were unusually good substrates. Under appropriate conditions, the E. coli amidase can synthesize amide bonds either directly or via a transpeptidation. Such an enzyme is therefore capable of transferring the penicillin side chain to amino acceptors in the cell. Such a reaction may actually occur.
The binding of [4C ]penicillin G to P. mirabilis was little inhibited by 6-aminopenicillanic acid (211) . In contrast, a structural ana- logue to the side chain, phenacetylglycine, prevented binding when present in only 10-fold excess. Moreover, although phenacetylglycine per se had no effect on cell growth, it prevented formation of spheroplasts in penicillin-treated cells. This result should be confirmed and extended.
CONTROL OF CELL WALL SYNTHESIS
Synthesis of the peptidoglycan is coupled to that of the other macromolecules of the cell. It would therefore be expected to involve complicated regulatory pathways. Although this regulation is essentially not understood, the action of penicillin could be intimately intertwined with these regulatory mechanisms. As already discussed, penicillin causes the accumulation of UDP-acetylmuramyl-pentapeptide in some (but not all) organisms. An undefined mechanism must therefore exist by which the enzymes responsible for utilizing this nucleotide are modulated either by the degree of cross-linking which occurs or else directly by the penicillin.
In a phenomenon which is quite closely related, the amount of linear peptidoglycan which bacteria will synthesize is strongly affected by the action of penicillin. In such organisms as S. aureus, low concentrations of penicillin lead to synthesis of uncross-linked peptidoglycan. At higher concentrations, peptidoglycan synthesis virtually ceases (229) . Such mechanisms are not universal. In P. mirabilis, peptidoglycan synthesis continues independent of the antibiotic concentrations (138) . Such effects of penicillin on the net synthesis of peptidoglycan are reflected in in vitro assays. In the case of E. coli, methicillin and ampicillin inhibit total peptidoglycan synthesis in vitro; penicillin G does not (105) . With M. luteus, penicillin G causes dramatic inhibition of synthesis (152) . An unanswered question is whether penicillin might sometimes kill by inhibiting cell wall synthesis by such a control mechanism. If so, the anomalous results on the effect of penicillin on crosslinking in gram-negative organisms might be explained.
A third interesting example of control is the so-called zone phenomenon described by Eagle et al. (61, 62, 68) . For some organisms, but not others, the rate at which penicillin kills the cells is decreased if the concentration of penicillin is increased beyond its optimal level. Two plausible explanations for this phenomenon exist. (i) Because synthesis of uncross-linked cell wall at low penicillin concentrations may be necessary for cell lysis, S. aureus H may be protected at high concentrations of penicillin because peptidoglycan synthesis is totally inhibited. (ii) Bacteria possess multiple PBCs, which vary in their affinities for penicillin. Inhibition of one component might lead to cell death, whereas inhibition of a less sensitive binding component, which might possess an antagonistic activity, would reduce the rate of killing. The B. subtilis system could provide an example of this second mechanism. At low penicillin concentration, the transpeptidase (presumably components I, II, and/or IV) is inhibited; higher penicillin concentrations inhibit the carboxypeptidase (component V) as well. If the action of the carboxypeptidase is indeed to limit the degree of peptidoglycan cross-linking, then its inhibition might well reduce the rate of bacteriolysis.
In some other organisms the antagonistic activity inhibited by penicillin at the higher concentration might be an autolysin such as the endopeptidase. Such an antagonistic action between autolysins and the cell wall synthetic enzymes has been clearly demonstrated in Pneumococcus (230) . In this organism, the normal autolytic activity could be suppressed if cells were grown in the presence of ethanolamine rather than choline. Under such conditions, the rate at which penicillin killed cells was reduced 10-fold. Likewise, mutants of B. subtilis and B. licheniformis have been isolated which are highly deficient in autolytic activity (79) . These mutants are lysed by two inhibitors of cell wall synthesis, vancomycin and cycloserine, only at concentrations 10-to 20-fold higher than those required to lyse the wild type (198) .
An extremely interesting finding, which should be pursued vigorously, is the demonstration of mutant strains of Staphylococcus (10) and Pediococcus cerevisiae (237, 238, 242) which are penicillin dependent. Such organisms may have resulted from antagonistic, penicillinsensitive activities becoming sufficiently out of balande during mutation to penicillin resistance so that partial inhibition of one activity became necessary for cell survival. Other models can of course be visualized, and determination of the actual explanation may have great importance for understanding the interaction of penicillin with the bacterial cell.
Induction of penicillinase synthesis may offer a promising and so far relatively unexploited approach to the study of regulation of cell wall synthesis. Irreversibly bound penicillin in B. cereus (6, 53, 58, 187, 188, 189, 191) induces penicillinase synthesis. Likewise, penicillinase is induced in S. aureus (103) in inhibiting peptidoglycan synthesis leads to transfer of information to the cytoplasm and activation of penicillinase synthesis. Although the entire receptor-transmitter complex might be components of the penicillinase system, another possibility is that some genetic elements involved in control of cell wall synthesis may also be involved in regulation of penicillinase production (37, 38 
